HiMedia’s COVID-19 Detection Kit detects the BF.7 variant

HiMedia’s COVID-19 Detection Kit detects the BF.7 variant


  • Post By :

  • Source: HiMedia

  • Date: 24 Dec,2022

HiMedia Laboratories announces that their RT-PCR kits are capable of detecting the recently discovered BF.7 SARS-CoV-2 variant. The portfolio includes:

1.MBPCR243 – A 4 Gene COVID-19 Multiplex Detection Kit

2.MBPCR255 – Hi-PCR® Triplex COVID-19 Detection Kit

The company tested the impact of the variant on their Triplex PCR Kit. Mutations, especially in RNA viruses are expected and SARS-CoV-2 is no exception.

“Multiplexing has the advantage of higher sensitivity as it detects more than one region of the target, while also being capable of detecting mutations. As the new variant is wreaking a havoc worldwide, it becomes imperative to test the accuracy of the existing kits” says Dr Rajas V Warke – Director of HiGenoMB® and Virology, HiMedia Labs.

To determine whether their RT-PCR kits can detect the BF.7 variant of the virus, the R&D team at HiGenoMB® analysed the sequenced data in depth. This CE-IVD and CDSCO approved kit that also detected the earlier variants such as The Delta and Omicron has shown 100% binding, indicating that the new found variant will not hamper the sensitivity of the kit (MBPCR255).

Dr Rajas adds, “As a leader in Molecular diagnostics, HiMedia® is committed to developing reliable, fast and accurate diagnostic kits that are an important tool to assess and contain the spread of virus.”

Please visit our website www.himedialabs.com for more details about HiGenoMB® products related to COVID Molecular testing.

About HiMedia Laboratories Pvt. Ltd.

HiMedia is one of the largest Indian Biosciences company, providing solutions to over 150 countries worldwide with an all-inclusive product range catering to Microbiology, Molecular Biology, Animal Cell culture, Plant Tissue culture, Bio chemicals, Laboratory Aids, Molecular Diagnostic instruments and more. HiGenoMB® encompasses the Molecular Biology Product Range of HiMedia Laboratories Pvt. Ltd. Comprising of DNA/RNA Extraction kits, PCR reagents, NASBA (Nucleic Acid Sequence Based Amplification tests), Proteomics, Molecular biology grade chemicals and buffers and Instrumentation for Research & Diagnostics. HiGenoMB® has now ventured into service industry with its Hi-Gx360TM services offering a complete portfolio of  Sequencing & Bioinformatics solutions in diverse areas. Covering major aspects of the most dynamic branches of the Life Sciences group, HiGenoMB® team strives hard to make molecular work enjoyable with its user friendly product range.


About Author